Skip to main content
Premium Trial:

Request an Annual Quote

John Thompson, J. Thomas Ranken

Premium
John Thompson is now chief executive officer of VizX Labs.
 
Thompson comes to the role with a background managing at the executive level in the venture capital, asset recovery, retail, information technology, financial services, distribution, and production industries.
 

Thompson replaces J. Thomas Ranken, who is leaving after seven years with VizX.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.